Announcements
- 2023.10.06 Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2023
- 2023.09.18 2023 Interim Report
- 2023.09.18 VOLUNTARY ANNOUNCEMENT ENROLLED IN FDA TOTAL PRODUCT LIFE CYCLE ADVISORY PROGRAM (TAP) PILOT
- 2023.09.05 Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2023
- 2023.08.28 INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2023
- 2023.08.16 DATE OF BOARD MEETING
- 2023.08.07 VOLUNTARY ANNOUNCEMENT COMPLETION OF THE FIRST FEE-FOR-SERVICE COMPASSIONATE USE TREATMENT WITH LUX-VALVE PLUS IN THE ASIA-PACIFIC REGION
- 2023.08.04 Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2023
- 2023.08.01 Articles of Association
- 2023.07.07 EARLY FEASIBILITY STUDY OF LUX-VALVE PLUS PRE-SUBMISSION ACCEPTED BY THE FDA
Privacy Law Copyright © Jenscare Scientific Co., Ltd. All rights reserved. 网站备案/许可证号：浙ICP备17016094号
